Tech Company Inital Public Offerings
Jaguar Animal Health IPO
Jaguar Animal Health, operating out of San Francisco, had an IPO event on 5/14/2015.
Transaction Overview
Company Name
Announced On
5/14/2015
Transaction Type
IPO
Amount
$20,000,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
201 Mission St. 2375
San Francisco, CA 94105
USA
San Francisco, CA 94105
USA
Phone
Website
Email Address
Overview
Jaguar Animal Health (NASDAQ: JAGX) is a biopharmaceutical company committed to becoming a leading supplier of animal health solutions that are naturally derived & sustainably harvested.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Lisa Conte
Chief Scientific Officer
Pravin Chaturvedi
Executive Vice President
Steven King
VP - Bus. Development
Ian Wendt
VP - Finance
Carol Lizak
VP - General Counsel
Jonathan Wolin
VP - Manufacturing
David Sesin
Browse more venture capital transactions:
Prev: 5/14/2015: NuSirt Biopharma venture capital transaction
Next: 5/14/2015: Smarking venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries on this site are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs